Learn more
Log in
0 followers
Design Therapeutics is pioneering novel small-molecule therapeutic candidates, called gene targeted chimeras (GeneTACs™), designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases.
Industries
Headquarters
Stage
Employees
Links
20 members
8 members
7 members
5 members
2 members
3 members
Crinetics Pharmaceuticals
1 follower
Sonoma Biotherapeutics
NYU Langone Health
10 followers
AbbVie
138 followers
Coursera
137 followers
Discover companies